Fibromyalgia: A Central Sensitivity Syndrome

Women and Health

Volumn , Issue , 2013, Pages 1331-1340

  Yunus, Muhammad B ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884045302     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-384978-6.00090-X     Document Type: Chapter

References (42)

1. Gowers W.R. Lumbago: its lessons and analogues. BMJ 1904, i:117-121.
2. Hench P.K. Nonarticular rheumatism. Twenty-second rheumatism review: review of the American and English literature for the years 1973 and 1974. Arthritis Rheum 1976, 19(Suppl.):1081-1089.
3. Yunus M.B., Masi A.T., Calabro J.J., Miller K.A., Feigenbaum S.L. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981, 11:151-171.
4. Yunus M.B. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum 2008, 37:339-352.
5. Yunus M.B. Primary fibromyalgia syndrome: current concepts. Comprehensive Therapy 1984, 10:21-28.
6. Yunus M.B. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007, 36:339-356.
7. Russell I.J., Larson A.A. Neurophysiopathogenesis of fibromyalgia syndrome: a unified hypothesis. Rheum Dis Clin North Am 2009, 35:421-435.
8. Yunus M.B. Central sensitivity syndromes: a unified concept for fibromyalgia and other similar maladies. J Indian Rheumatism Assoc 2000, 8:27-33.
9. Kindler L.L., Bennett R.M., Jones K.D. Central sensitivity syndromes: mounting pathophysiologic evidence to link fibromyalgia with other common chronic pain disorders. Pain Management Nursing 2011, 12:15-24.
10. Woolf C. Central sensitization: implications for the diagnosis and treatment of pain. Pain 2010, 152:S2-S15.
11. Winfield J.B. Fibromyalgia and related central sensitivity syndromes: twenty-five years of progress. Semin Arthritis Rheum 2007, 36:335-338.
12. Cohen S.A. Physiology of pain. Principles and practice of pain medicine 2004, 35-48. McGraw Hill, New York. C.A. Warfield, Z.H. Bajwa (Eds.).
13. Watkins L.R., Milligan E.D., Maier S.F. Glial activation: a driving force for pathologic pain. Trends Neurosci 2001, 24:450-455.
14. Buskila D., Neumann L., Vaisberg G., et al. Increased rate of fibromyalgia following cervical spine injury. Arthritis Rheum 1997, 40:446-452.
15. Vierck C.J. Mechanisms underlying development of spatially distributed chronic pain (fibromyalgia). Pain 2006, 124:242-263.
16. Norbury T.A., MacGregor A.J., Urwin J., et al. Heritability of responses to painful stimuli in women: a classical twin study. Brain 2007, 130:3041-3049.
17. Staud R., Nagel S., Robinson M.E., Price D.D. Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study. Pain 2009, 145:96-104.
18. Niddam D., Chan R.-C., Lee S.-H., et al. Central representation of hyperalgesia from myofascial trigger point. NeuroImage 2008, 39:1299-1306.
19. Yunus MB. The prevalence of fibromyalgia in other chronic pain conditions. Pain Res Treat 2012:58473.
20. Buskila D. Genetics of chronic pain states. Best pract Res Clin Rheumatol 2007, 21:535-547.
21. Nebel M.B., Gracely R.H. Neuroimaging of fibromyalgia. Rheum Dis Clin North Am 2009, 35:313-327.
22. Sorensen J., Graven-Nielsen T., Henriksson K.G., et al. Hyperexcitability in fibromyalgia. J Rheumatol 1998, 25:151-155.
23. Desmeules J.A., Cedraschi C., Rapiti E., et al. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 2003, 48:1420-1429.
24. Robinson M.E., Craggs J.G., Price D.D., et al. Gray matter volume of pain-related brain areas are decreased fibromyalgia syndrome. J Pain 2011, 12:436-443.
25. Russell I.J., Raphael K.G. Fibromyalgia syndrome:presentation, diagnosis, differential diagnosis, and vulnerability. CNS Spectrum 2008, 13(3, Suppl. 5):6-11.
26. Yunus M.B. Role of central sensitization in symptoms beyond muscle pain, and the evaluation of a patient with widespread pain. Best Pract Res Clin Rheumatol 2007, 21:481-497.
27. Wolfe F., Smythe H.A., Yunus M.B., et al. American college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 1990, 33:160-172.
28. Wolfe F., Clauw D.J., Fitzcharles M.-A., et al. The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010, 62:600-610.
29. Yunus M.B., Arslan S., Aldag J.C. Relationship between body mass index and fibromyalgia features. Scan J Rheumatol 2002, 31:27-31.
30. Mork P.J., Vasseljen O., Nelsen T.I. Association between physical exercise, body mass index and risk of fibromyalgia: longitudinal data from the Norwegian Trondelag health study. Arthritis Care Res (Hoboken) 2010, 62:611-617.
31. Yunus M.B., Arslan S., Aldag J.C. Relationship between fibromyalgia features and smoking. Scand J Rheumatol 2002, 31(5):301-305.
32. Shapiro J.R., Anderson D.A., Danoff-Burg S. A pilot study of the effects of behavioral weight loss treatment on fibromyalgia symptoms. J Psychosom Res 2005, 59:275-282.
33. Seidel M.F., Muller W. Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5HT3 antagonists. Expert Opin Pharmacother 2011, 12:1381-1391. [Epub 2011, Feb 7].
34. Van Houdenhove B. Customizing treatment of chronic fatigue syndrome and fibromyalgia: the role of perpetuating factors. Psychosomatics 2008, 49:470-477.
35. Sumpton J.E., Moulin D.E. Fibromyalgia: presentation and management with a focus on pharmacological treatment. Pain Res Manage 2008, 13:477-483.
36. Arnold L.M. Strategies for managing fibromyagia. Am J Med 2009, 122:S31-SS43.
37. Holman A.J., Myers R.R. A randomized double-blind placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 2005, 52:2495-2505.
38. Russell I.J., Holman A.J., Swick T.J., et al. Sodium oxybate reduces pain, fatigue and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind placebo-controlled study. Pain 2011, 152:1007-1017.
39. Arnold L.M., Hess E.V., Hudson J.I., et al. A randomized, placebo-controlled, double-blind flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 2002, 112:191-197.
40. Wolfe F., Cathey M.A., Hawley D.J. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol 1994, 23:255-259.
41. Ables A.Z., Nagubilli R. Prevention, recognition and management of serotonin syndrome. Am Fam Physician 2010, 81:1139-1142.
42. Yunus M.B., Masi A.T., Aldag J.C. Short-term effects of ibuprofen in primary fibromyalgia syndrome: a double blind, placebo controlled trial. J Rheumatol 1989, 16:527-532.